Log In
Sign Up
Find a Lawyer
Ask a Lawyer
Research the Law
Law Schools
Laws & Regs
Newsletters
Marketing Solutions
Justia Connect
Pro Membership
Basic Membership
Justia Lawyer Directory
Platinum Placements
Gold Placements
Justia Elevate
SEO
Websites
Blogs
Justia Amplify
PPC Management
Google Business Profile
Social Media
Justia Onward Blog
Justia
Patents
Patents Assigned to Biostrands S.r.l.
Patents Assigned to Biostrands S.r.l.
Human recombinant antibody against the hepatitis C (HCV) non structural NS3 protein nucleic acid and uses thereof
Patent number:
7314919
Abstract:
An human antibody anti-NS3 protein of the hepatitis C virus (HCV) is described, as will as synthetic and recombinant fragments thereof able to inhibit the helicase activity of the NS3 protein, both in vitro and in vivo, and uses thereof.
Type:
Grant
Filed:
June 11, 2002
Date of Patent:
January 1, 2008
Assignee:
Biostrands S.r.l.
Inventors:
Roberto Burioni, Massimo Clementi